HCL AXON’s Unique Solutions
iPharma – for rapid deployment of a robust CRM solution
HCL AXON’s iPharma solution is the result of a remarkable combination of Oracle’s Siebel Pharma SFA and HCL AXON’s extensive domain expertise in the Life Sciences vertical (strong Siebel competency & knowledge of Siebel Pharma). This advanced, readily deployable and user-friendly Siebel CRM solution empowers Pharma companies to manage their Sales Force efficiently. IPharma’s clear edge can be seen in areas such as Territory Objectives Management, Physician Segmentation & Targeting, Account Profiling, Call Planning, Call Reporting & Activity Management, Support for Ops Team, KOL Management & Call List, District Manager Support, Feedback & Coaching, Knowledge Management, Role based Report Analytics, HCP Spent Compliance, Expense Management, Quota & Incentive Management, and Events Management.iPharma is a boon for:
Your Management Team, as it provides/enables (1) better visibility & control, (2) increases sales force effectiveness, (3) provides territory analysis & KOL management, (4) compliance to gift reporting laws, (5) implementation & ROI analysis, and (6) strategic decision making while tracking productivity.
Your Marketing Team, as it provides/enables (1) brand trend analysis, (2) improved customer segmentation, (3) customer feedback, (4) promotion effectiveness, (5) real time ROI analysis, and (6) program implementation analysis .
Your Sales Team, as it provides/enables (1) efficient time management, (2) efficient TL management, (3) timely feed back to sales reps, (4) user friendly & intuitive work flows, (5) instant real time access to sales team activities, and (6) enhanced customer focus & productivity.
BA/BE Solution - For drug manufacturers
BA/BE studies are conducted by generic drug manufacturers. A proprietary medicinal product will be regarded as essentially similar to another product if it has the same qualitative and quantitative composition in terms of active principles (substances), and the pharmaceutical form is the same and, where necessary, bioequivalence with the first product has been demonstrated by appropriate bioavailability studies carried out.Solution Description
The BA/BE Solution allows drug manufacturing and various clinical research organization to securely track the BA/BE studies progress in a systematic manner and provides first hand information about the status at any given point in time. Also provides consolidated reports for every stage of the study starting from feasibility/study confirmation till final report dispatch meeting all regulatory standards including 21 CFR Part 11.
OPSM Solution
In an attempt to help ensure only authentic pharmaceutical products are distributed through the supply chain, some regulatory agencies have implemented or are considering provisions requiring a “pedigree” for drug products. A Pedigree is a certified record that contains information about each distribution and transfer of ownership of a prescription drug. It contains product information, transaction information, distributor information, recipient information, and signatures. Pedigree mandates are evolving and they generally require tracking, tracing and authentication of the entire chain of drug custody. Moreover, analysts estimated that counterfeit and diverted drugs, as well as drug recall, cost the industry over $30B annually
OPSM is a new Oracle Application built as an extension to existing customer ERP systems (Oracle, SAP, etc.) that enables customers to implement mass-serialization of drug products and share serialized product data across the supply chain in various electronic formats, including electronic pedigree. It is an edge application designed to address drug package serialization capabilities without necessitating full serial tracking in the ERP Transactional system
OPSM will be fully integrated for Oracle EBS customers and will be built on open standards to allow integration with other ERP transaction systems, such as Oracle JD Edwards EnterpriseOne, Oracle JD Edwards World, Oracle PeopleSoft Enterprise and SAP
HCL AXON and Oracle will be engaged in co-development of Process Integration Packs for OPSM and Oracle E-Business Suite (EBS) using AIA foundation and methodology. The PIPs being developed are OPSM & EBS 11.5.10, OPSM & EBS 12.1, and OPSM Local to OPSM Enterprise Integration. This will help business to respond in real time to business process changes and uses SOA to provide:
- Business Process Flexibility
- End-to-End Business Process Management
- Sustainable Best of Breed Integrations
